Physician profile
Jon Swenson
NPI 1831168384
$882.54
in general payments reported to CMS, 2019-2025
9 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $73.65 · 2021: $11.12 · 2022: $149 · 2023: $42.56 · 2024: $146 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $238.72 | 2019-2024 | Insignia, Mako |
| Zimmer Biomet Holdings, INC. | $236.07 | 2024-2025 | Persona, Tricera Handpiece, Comprehensive Shoulder System |
| Amgen INC. | $145.39 | 2020-2025 | Evenity, Prolia, Prolia |
| Bioventus LLC | $138.46 | 2022-2024 | Supartz Fx Sodium Hyaluronate, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $63.70 | 2019-2024 | Fms |
| Allergan, INC. | $16.06 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.79 | 2019 | |
| Smith+Nephew, INC. | $15.54 | 2025 | Pico, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl |
| Endo Pharmaceuticals INC. | $12.81 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Swenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.